Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Preferred Stock Liabilities (2016)

Anaptysbio's Preferred Stock Liabilities history spans 1 years, with the latest figure at $40.7 million for Q4 2016.

  • For Q4 2016, Preferred Stock Liabilities changed N/A year-over-year to $40.7 million; the TTM value through Dec 2016 reached $40.7 million, changed N/A, while the annual FY2016 figure was $40.7 million, N/A changed from the prior year.
  • Preferred Stock Liabilities reached $40.7 million in Q4 2016 per ANAB's latest filing.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $40.7 million in Q4 2016 to a low of $40.7 million in Q4 2016.